[HTML][HTML] PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines

P Lotfinejad, T Kazemi, S Safaei, M Amini… - Biomedicine & …, 2021 - Elsevier
… Fragmentation of DNA indicated the role of PD-L1-siRNA in the activation of apoptosis
mechanism in … Furthermore, PD-L1 is critical to promote stem cell-like properties in breast

Recent advances in cancer stem cell-targeted immunotherapy

N Badrinath, SY Yoo - Cancers, 2019 - mdpi.com
PD-L1 expression on CSCs of breast cancer promotes the … These expressions sustain
the stemness of breast cancer through the activation of the PI3K/AKT pathway [40]. Apart from …

[HTML][HTML] Stem cell therapy: A paradigm shift in breast cancer treatment

S Khan, M Suryavanshi, J Kaur, D Nayak… - … journal of stem cells, 2021 - ncbi.nlm.nih.gov
… population by activating Ras-MAPK and PI3K/AKT pathways[54] … to sustain the cells of the
TME. In this way the TME and … Furthermore, the elevated expression of PD-L1 on BCSCs is …

The expression and function of PD-L1 in CD133 (+) human liver cancer stem-like cells

YD Bai, ML Shi, SQ Li, XL Wang, JJ Peng… - Zhonghua Zhong liu …, 2023 - europepmc.org
… molecular mechanism of PD-L1 regulating stem cell characteristics, … was knockdown by
siRNA, the expressions of CD133, Nanog, … crucial to maintain stemness and promotes the tumor …

E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities

Q Zou, M Liu, K Liu, Y Zhang, BJ North, B Wang - Cellular Oncology, 2023 - Springer
… migration and invasion by maintaining stability of Nanog [44,… the PI3K/AKT/mTOR signaling
pathway exacerbates breast … anti-cancer immunity by regulating PD-1 or PD-L1 expression. …

[HTML][HTML] Mutual connected il-6, egfr and lin28/let7-related mechanisms modulate pd-L1 and igf upregulation in hnscc using immunotherapy

J Li, Y Xiao, H Yu, X Jin, S Fan, W Liu - Frontiers in Oncology, 2023 - frontiersin.org
… was shown to promote PD-L1 degradation and inhibit PD-L1 … positive feedback loop that
sustains the altered malignant state … biomarker for PI3K/Akt pathway activation and PTEN status, …

[HTML][HTML] Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

L Therachiyil, OJ Hussein, S Uddin… - Seminars in Cancer …, 2022 - Elsevier
… (OCT4), SRY-box transcription factor 2 (SOX2), homeobox protein (… This in turn enhances
tumorigenesis, tumor proliferation, … AhR regulates tumorigenesis by maintaining CSC …

Platelet PD-L1 inhibits storage-induced apoptosis by sustaining activation of the AKT signalling pathway

S Chen, J Han, H Deng, Y Lu, Z Wang, Q Zhang… - Thrombosis …, 2024 - Elsevier
breast cancer cells, melanoma cells, and colon cancer cells … BMS-1166 can promote the
formation of PD-L1 dimers, the … and that PD-L1 sustains PI3K/AKT pathway activation in a wide …

The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

A Emami Nejad, S Najafgholian, A Rostami… - Cancer Cell …, 2021 - Springer
… : altering gene expression, the activation of oncogenes, … The HIFs promote the expression
of more than 150 genes, … and refers to the sustained restriction in oxygen diffusion by …

Insights into new mechanisms and models of cancer stem cell multidrug resistance

Y Garcia-Mayea, C Mir, F Masson, R Paciucci… - Seminars in cancer …, 2020 - Elsevier
… Hippo pathway has been involved in maintaining stemness … pathways involved in such
conditions is PI3K-AKT signaling [… , it has been shown that tumors with high expression of PD-L1